DK0877019T3 - Substituerede diaminocarboxylsyrer - Google Patents
Substituerede diaminocarboxylsyrerInfo
- Publication number
- DK0877019T3 DK0877019T3 DK98108040T DK98108040T DK0877019T3 DK 0877019 T3 DK0877019 T3 DK 0877019T3 DK 98108040 T DK98108040 T DK 98108040T DK 98108040 T DK98108040 T DK 98108040T DK 0877019 T3 DK0877019 T3 DK 0877019T3
- Authority
- DK
- Denmark
- Prior art keywords
- diaminocarboxylic acids
- substituted
- substituted diaminocarboxylic
- acids
- diaminocarboxylic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
- C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19719585A DE19719585A1 (de) | 1997-05-09 | 1997-05-09 | Substituierte Diaminocarbonsäuren |
| DE19719428A DE19719428A1 (de) | 1997-05-12 | 1997-05-12 | Substituierte Diaminocarbonsäuren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0877019T3 true DK0877019T3 (da) | 2002-04-08 |
Family
ID=26036417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98108040T DK0877019T3 (da) | 1997-05-09 | 1998-05-02 | Substituerede diaminocarboxylsyrer |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US6159995A (da) |
| EP (1) | EP0877019B1 (da) |
| JP (1) | JP4177484B2 (da) |
| KR (1) | KR19980086893A (da) |
| AR (1) | AR012675A1 (da) |
| AT (1) | ATE210639T1 (da) |
| AU (1) | AU736700B2 (da) |
| BR (1) | BR9801604A (da) |
| CA (1) | CA2237052A1 (da) |
| CZ (1) | CZ143998A3 (da) |
| DE (1) | DE59802394D1 (da) |
| DK (1) | DK0877019T3 (da) |
| ES (1) | ES2165640T3 (da) |
| HU (1) | HUP9801045A3 (da) |
| ID (1) | ID20809A (da) |
| PL (1) | PL326218A1 (da) |
| PT (1) | PT877019E (da) |
| TR (1) | TR199800818A3 (da) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19719621A1 (de) * | 1997-05-09 | 1998-11-12 | Hoechst Ag | Sulfonylaminocarbonsäuren |
| US6410580B1 (en) | 1998-02-04 | 2002-06-25 | Novartis Ag | Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases |
| KR20010040698A (ko) * | 1998-02-04 | 2001-05-15 | 한스 루돌프 하우스, 헨리테 브룬너, 베아트리체 귄터 | 기질 분해 메탈로프로테이나제를 억제하는 술포닐아미노유도체 |
| AU756248B2 (en) * | 1998-04-03 | 2003-01-09 | Sankyo Company Limited | Sulfonamide derivatives |
| ES2187171T3 (es) * | 1998-07-16 | 2003-05-16 | Aventis Pharma Gmbh | Derivados de acidos fosfinico y fosfonico en calidad de medicamentos. |
| KR20010102485A (ko) | 1999-03-03 | 2001-11-15 | 데이비드 엠 모이어 | 디헤테로-치환된 메탈로프로테아제 저해제 |
| MXPA01008855A (es) * | 1999-03-03 | 2002-07-02 | Procter & Gamble | Inhibidores de metaloproteasa que contienen alquenilo y alquinilo. |
| GB9918684D0 (en) | 1999-08-09 | 1999-10-13 | Novartis Ag | Organic compounds |
| GB0103303D0 (en) * | 2001-02-09 | 2001-03-28 | Novartis Ag | Organic compounds |
| US6506786B2 (en) * | 2001-02-13 | 2003-01-14 | Pharmacor Inc. | HIV protease inhibitors based on amino acid derivatives |
| AU2002256672A1 (en) * | 2001-03-14 | 2002-09-24 | Novartis Ag | Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors. |
| SE0100903D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
| SE0100902D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
| SE0103710D0 (sv) * | 2001-11-07 | 2001-11-07 | Astrazeneca Ab | Compounds |
| PE20030701A1 (es) | 2001-12-20 | 2003-08-21 | Schering Corp | Compuestos para el tratamiento de trastornos inflamatorios |
| SE0202539D0 (sv) * | 2002-08-27 | 2002-08-27 | Astrazeneca Ab | Compounds |
| GB0221246D0 (en) * | 2002-09-13 | 2002-10-23 | Astrazeneca Ab | Compounds |
| GB0412553D0 (en) * | 2004-06-04 | 2004-07-07 | Univ Aberdeen | Therapeutic agents for the treatment of bone conditions |
| SE0401762D0 (sv) * | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Novel compounds |
| US7648992B2 (en) | 2004-07-05 | 2010-01-19 | Astrazeneca Ab | Hydantoin derivatives for the treatment of obstructive airway diseases |
| US7388008B2 (en) * | 2004-08-02 | 2008-06-17 | Ambrilia Biopharma Inc. | Lysine based compounds |
| SE0403086D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Compounds |
| SE0403085D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Novel componds |
| US7576222B2 (en) | 2004-12-28 | 2009-08-18 | Wyeth | Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase |
| CA2606025A1 (en) * | 2005-04-27 | 2006-11-02 | Ambrilia Biopharma Inc. | Method for improving pharmacokinetics of protease inhibitors and protease inhibitor precursors |
| AU2006319716B2 (en) * | 2005-11-30 | 2012-02-02 | Taimed Biologics, Inc. | Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation |
| CA2664118A1 (en) | 2006-09-21 | 2008-07-03 | Ambrilia Biopharma Inc. | Protease inhibitors |
| TW200831488A (en) * | 2006-11-29 | 2008-08-01 | Astrazeneca Ab | Novel compounds |
| US8093265B2 (en) | 2007-03-09 | 2012-01-10 | Renovis, Inc. | Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
| GB0705400D0 (en) | 2007-03-21 | 2007-05-02 | Univ Aberdeen | Therapeutic compounds andm their use |
| GB0817207D0 (en) | 2008-09-19 | 2008-10-29 | Pimco 2664 Ltd | therapeutic apsac compounds and their use |
| GB0817208D0 (en) | 2008-09-19 | 2008-10-29 | Pimco 2664 Ltd | Therapeutic apsap compounds and their use |
| GB201311361D0 (en) | 2013-06-26 | 2013-08-14 | Pimco 2664 Ltd | Compounds and their therapeutic use |
| WO2016097001A1 (en) | 2014-12-17 | 2016-06-23 | Pimco 2664 Limited | N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and n-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)-benzenesulfonamide compounds and their therapeutic use |
| US11289654B2 (en) | 2016-12-22 | 2022-03-29 | Guangzhou Chinaray Optoelectronic Materials Ltd. | Polymers containing furanyl crosslinkable groups and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2764262B2 (ja) * | 1987-08-28 | 1998-06-11 | 持田製薬株式会社 | ヒダントイン誘導体及びそれを有効成分とする医薬組成物 |
| TW201303B (da) * | 1990-07-05 | 1993-03-01 | Hoffmann La Roche | |
| US5455258A (en) * | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
| US5506242A (en) * | 1993-01-06 | 1996-04-09 | Ciba-Geigy Corporation | Arylsufonamido-substituted hydroxamic acids |
| AU690703B2 (en) * | 1994-06-22 | 1998-04-30 | British Biotech Pharmaceuticals Limited | Metalloproteinase inhibitors |
| US5863949A (en) * | 1995-03-08 | 1999-01-26 | Pfizer Inc | Arylsulfonylamino hydroxamic acid derivatives |
| PT821671E (pt) * | 1995-04-20 | 2001-04-30 | Pfizer | Derivados do acido arilsulfonil hidroxamico como inibidores de mmp e tnf |
| KR980009238A (ko) * | 1995-07-28 | 1998-04-30 | 우에노 도시오 | 설포닐아미노산 유도체 |
| ATE225779T1 (de) * | 1995-11-17 | 2002-10-15 | Warner Lambert Co | Sulfonamidinhibitoren von matrix metalloproteinasen |
| AU2792097A (en) | 1996-05-24 | 1998-01-05 | Ono Pharmaceutical Co. Ltd. | Phenylsulfonamide derivatives |
-
1998
- 1998-05-02 DE DE59802394T patent/DE59802394D1/de not_active Expired - Lifetime
- 1998-05-02 DK DK98108040T patent/DK0877019T3/da active
- 1998-05-02 EP EP98108040A patent/EP0877019B1/de not_active Expired - Lifetime
- 1998-05-02 AT AT98108040T patent/ATE210639T1/de not_active IP Right Cessation
- 1998-05-02 PT PT98108040T patent/PT877019E/pt unknown
- 1998-05-02 ES ES98108040T patent/ES2165640T3/es not_active Expired - Lifetime
- 1998-05-07 TR TR1998/00818A patent/TR199800818A3/tr unknown
- 1998-05-07 AR ARP980102140A patent/AR012675A1/es unknown
- 1998-05-07 CZ CZ981439A patent/CZ143998A3/cs unknown
- 1998-05-07 ID IDP980666A patent/ID20809A/id unknown
- 1998-05-07 CA CA002237052A patent/CA2237052A1/en not_active Abandoned
- 1998-05-08 BR BR9801604A patent/BR9801604A/pt not_active IP Right Cessation
- 1998-05-08 AU AU64824/98A patent/AU736700B2/en not_active Ceased
- 1998-05-08 HU HU9801045A patent/HUP9801045A3/hu unknown
- 1998-05-08 US US09/074,587 patent/US6159995A/en not_active Expired - Lifetime
- 1998-05-08 PL PL98326218A patent/PL326218A1/xx unknown
- 1998-05-08 JP JP16270798A patent/JP4177484B2/ja not_active Expired - Fee Related
- 1998-05-09 KR KR1019980016598A patent/KR19980086893A/ko not_active Application Discontinuation
-
2000
- 2000-10-18 US US09/690,475 patent/US6355673B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9801045A3 (en) | 2000-09-28 |
| HU9801045D0 (en) | 1998-07-28 |
| EP0877019A1 (de) | 1998-11-11 |
| TR199800818A2 (xx) | 1998-11-23 |
| US6159995A (en) | 2000-12-12 |
| CZ143998A3 (cs) | 1998-11-11 |
| HUP9801045A2 (hu) | 1999-06-28 |
| PL326218A1 (en) | 1998-11-23 |
| AU736700B2 (en) | 2001-08-02 |
| ES2165640T3 (es) | 2002-03-16 |
| CA2237052A1 (en) | 1998-11-09 |
| BR9801604A (pt) | 1999-06-08 |
| PT877019E (pt) | 2002-05-31 |
| US6355673B1 (en) | 2002-03-12 |
| ID20809A (id) | 1999-03-11 |
| JPH11228529A (ja) | 1999-08-24 |
| AU6482498A (en) | 1998-11-12 |
| KR19980086893A (ko) | 1998-12-05 |
| JP4177484B2 (ja) | 2008-11-05 |
| TR199800818A3 (tr) | 1998-11-23 |
| AR012675A1 (es) | 2000-11-08 |
| ATE210639T1 (de) | 2001-12-15 |
| EP0877019B1 (de) | 2001-12-12 |
| DE59802394D1 (de) | 2002-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE59802394D1 (de) | Substituierte Diaminocarbonsäuren | |
| DK0877018T3 (da) | Sulfonylaminocarboxylsyrer | |
| EE200000573A (et) | Asendatud indoolalkaanhapped | |
| ATE250583T1 (de) | Substituierte 3-cyanochinoline | |
| DE59813487D1 (de) | Substituierte 4-benzoyl-pyrazole | |
| DE69808366D1 (de) | Dimmer | |
| DE59804564D1 (de) | Flachstrahler | |
| ID20656A (id) | Ko-produksi ester | |
| DE59809916D1 (de) | Flachstrahler | |
| ID21536A (id) | Pembuatan ester | |
| ATE244705T1 (de) | Substituierte 4-benzoyl-pyrazole | |
| DE69809903D1 (de) | Erhöhter bodenbelag | |
| DE29720639U1 (de) | Teppichboden | |
| DE29703123U1 (de) | Bodenbelag | |
| ID24079A (id) | Aminoheteroksiklilamida tersubstitusi | |
| DE59807877D1 (de) | Substituierte 4-benzoyl-pyrazole | |
| FI972138A0 (fi) | Returtraog i bestrykningsanordning | |
| DE59810960D1 (de) | Substituierte phenyluracile | |
| DE29704697U1 (de) | Fußbodenbelag | |
| DE29723366U1 (de) | Dimmer | |
| DE59811399D1 (de) | Substituierte phenyluracile | |
| FI974354A0 (fi) | Kvaevereducering i avloppsvatten | |
| FI971698A0 (fi) | Klingstyrenhet i en cirkelsaog | |
| FI974635A0 (fi) | I vaermebatteri integrerbar ventilkonstruktion | |
| FI974373A0 (fi) | Avgasutlopp i utombordsmotorer |